Symbol: CIPLA
Month: 2024-07
Start Price: ₹1466.66
End Price: ₹1531.32
12M Return: 4.41%
6M Return: 4.41%
3M Return: 4.41%
Volatility: 0.231
Sharpe Ratio: 2.354
Max Drawdown: -0.029
Peer Correlation (SUNPHARMA): 0.6627
Peer Correlation (DIVISLAB): 0.7131
Peer Correlation (GRASIM): 0.5112
Average Peer Correlation: 0.629

Generate a short summary and suggest whether to BUY, SELL, or HOLD.

--- LLM Output ---
**Summary:**

Cipla (CIPLA) has demonstrated a steady performance over the past 12 months, with a return of 4.41%. The stock's volatility is relatively low at 0.231, indicating a stable price movement. The Sharpe Ratio of 2.354 suggests that the returns are generated with minimal risk. The Max Drawdown of -0.029 indicates that the stock has not experienced significant downturns. Correlation analysis reveals that CIPLA has a moderate to high correlation with its peers in the pharmaceutical industry, particularly with SUNPHARMA and DIVISLAB.

**Recommendation:**

Based on the analysis, I suggest a **BUY** recommendation for CIPLA. The stock's stable performance, low volatility, and attractive Sharpe Ratio indicate that it is a relatively safe investment opportunity. The moderate to high correlation with its peers also suggests that CIPLA is in line with industry trends. With a 4.41% return over the past 12 months, the stock appears to be a good investment opportunity for those seeking stable returns in the pharmaceutical sector.